Position in FHTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$172,268
+$101,807 QoQ
Shares Held
35,301
+139.5% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 102 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FHTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. FHTX ranks #258 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in FHTX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $172,268 | 35,301 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $70,461 | 14,741 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $209,277 | 38,755 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $119,676 | 24,474 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $98,902 | 21,043 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $58,895 | 16,136 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $74,769 | 15,841 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $110,630 | 11,883 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $53,314 | 9,272 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $40,790 | 6,079 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $33,965 | 5,266 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $20,330 | 4,066 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $59,713 | 8,482 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $57,485 | 9,272 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $34,381 | 5,389 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,148 | 367 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $7,643 | 562 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $62,534 | 4,106 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $249,603 | 10,914 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $405 | 38 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $29,668 | 2,251 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $75,951 | 3,747 | Shares | Defined | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||